Mannkind (MNKD) Current Deferred Revenue (2014 - 2026)
Mannkind's (MNKD) quarterly Current Deferred Revenue came in at $11.5 million in Q1 2026, down 1.97% year-on-year from $11.8 million in Q1 2025, and down 24.83% on a QoQ basis from $15.3 million in Q4 2025.
Mannkind (MNKD) Current Deferred Revenue (2014 - 2026) Analysis & Trends
Mannkind (MNKD) has 13 years of Current Deferred Revenue data on file, last reported at $11.5 million in Q1 2026.
- On a quarterly basis, Current Deferred Revenue fell 1.97% year-over-year to $11.5 million in Q1 2026; TTM through Mar 2026 was $11.5 million, a 1.97% decrease from a year earlier, with the FY2025 full-year figure at $15.3 million, down 75.88% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $11.5 million, down from $15.3 million in the prior quarter.
- Over the last five years, Current Deferred Revenue for MNKD reached as high as $78.9 million in Q4 2023 and fell as low as $1.3 million in Q1 2022.
- Historically, Current Deferred Revenue has averaged $22.2 million across 5 years, with a median of $10.1 million in 2025.
- Across the five-year window, Current Deferred Revenue tumbled 94.95% in 2022 and jumped 5829.61% in 2023, its largest moves.
- Year by year, Current Deferred Revenue stood at $63.6 million in 2022, then advanced by 24.09% to $78.9 million in 2023, then fell by 19.41% to $63.6 million in 2024, then tumbled by 75.88% to $15.3 million in 2025, then declined by 24.83% to $11.5 million in 2026.
- Per Business Quant data, the three most recent Current Deferred Revenue figures were $11.5 million in Q1 2026, $15.3 million in Q4 2025, and $10.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.53 Mn |
| Dec 31, 2025 | 15.33 Mn |
| Sep 30, 2025 | 10.12 Mn |
| Jun 30, 2025 | 10.95 Mn |
| Mar 31, 2025 | 11.76 Mn |
| Dec 31, 2024 | 63.57 Mn |
| Sep 30, 2024 | 6.52 Mn |
| Jun 30, 2024 | 7.42 Mn |
| Mar 31, 2024 | 7.60 Mn |
| Dec 31, 2023 | 78.88 Mn |
| Sep 30, 2023 | 3.67 Mn |
| Jun 30, 2023 | 3.49 Mn |
| Mar 31, 2023 | 77.50 Mn |
| Dec 31, 2022 | 63.57 Mn |
| Sep 30, 2022 | 1.79 Mn |
| Jun 30, 2022 | 1.67 Mn |
| Mar 31, 2022 | 1.31 Mn |
| Dec 31, 2021 | 20.37 Mn |
| Sep 30, 2021 | 14.02 Mn |
| Jun 30, 2021 | 20.13 Mn |